Primary Immunodeficiency

CAMBRIDGE, Massachusetts, January 22, 2026 — Takeda Pharmaceutical Company Limited announced the U.S. availability of GAMMAGARD LIQUID ERC, the...

FORT LEE, N.J., October 9, 2025 — Kedrion Biopharma today announced the U.S. commercial launch of YIMMUGO® (Immune Globulin...

September 29, 2025 – Kedrion Biopharma announced a major regulatory and strategic milestone with the U.S. Food and Drug...